Effect of mexiletine on monophasic action potentials recorded from the right ventricle in man.
The effect of mexiletine, a new antiarrhythmic agent, on ventricular refractoriness and monophasic action potentials recorded from the right ventricle was studied in nine subjects. The effective refractory period of the right ventricle was determined by the extra stimulus technique using a pacing electrode situated at the right ventricular apex. Following this determination the right ventricular apex was paced at a constant cycle length and premature stimuli were introduced starting at a coupling interval of 2 ms greater than the ventricular refractory period and then at progressively increasing coupling intervals of 5 ms increments. Simultaneous recordings of monophasic action potentials of both the regular paced beats and the induced premature beats were made using a  specially designed suction electrode catheter. The monophasic action potential durations were measured at 50% and 90% repolarisation. All these control measurements were repeated after an intravenous dose of 2 mg.kg-1 body wt. of mexiletine. The results showed that mexiletine did not significantly change the effective ventricular refractory period nor did it alter the monophasic action potential duration of the regular paced beat. The drug did, however, significantly prolong the monophasic action potential duration of the early induced premature beats and it is possible that this property of the drug may be related to its antiarrhythmic activity.
D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D006328:Cardiac Catheterization / Q000379:methods; D002304:Cardiac Pacing, Artificial; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000494:pharmacology*; D008875:Middle Aged; D009200:Myocardial Contraction; D011437:Propylamines / Q000494:pharmacology*; D016276:Ventricular Function
D011437:Propylamines; D008801:Mexiletine